XML 73 R51.htm IDEA: XBRL DOCUMENT v3.25.0.1
Fair Value Measurements (Tables)
 12 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of fair values of financial assets and liabilities measured on a recurring basis
The following tables present assets and liabilities that are measured at fair value on a recurring basis as of the dates presented:
Level 1Level 2Level 3Totals
December 31, 2024
Financial assets:
Securities available for sale$— $831,013 $— $831,013 
Total securities available for sale— 831,013 — 831,013 
Derivative instruments— 38,954 — 38,954 
Mortgage loans held for sale in loans held for sale— 246,171 — 246,171 
Total financial assets$— $1,116,138 $— $1,116,138 
Financial liabilities:
Derivative instruments$— $32,268 $— $32,268 
Level 1Level 2Level 3Totals
December 31, 2023
Financial assets:
Securities available for sale:
Other available for sale securities$— $923,279 $— $923,279 
Total securities available for sale— 923,279 — 923,279 
Derivative instruments— 37,151 — 37,151 
Mortgage loans held for sale in loans held for sale— 179,756 — 179,756 
Total financial assets$— $1,140,186 $— $1,140,186 
Financial liabilities:
Derivative instruments$— $33,608 $— $33,608 
Schedule of impaired loans measured at fair value on a nonrecurring basis Consolidated Balance Sheets at period end and the level within the fair value hierarchy each is classified: 
Level 1Level 2Level 3Totals
December 31, 2024
Individually evaluated loans, net of allowance for credit losses$— $— $38,374 $38,374 
OREO— — 3,666 3,666 
Total$— $— $42,040 $42,040 
Level 1Level 2Level 3Totals
December 31, 2023
Individually evaluated loans, net of allowance for credit losses$— $— $21,303 $21,303 
Total$— $— $21,303 $21,303 
Schedule of OREO measured at fair value on a nonrecurring basis
The following table presents, as of December 31, 2024, OREO measured at fair value on a nonrecurring basis that was still held in the Consolidated Balance Sheets at period-end. There was no impairment recognized during 2023 of OREO assets still held in the Consolidated Balance Sheets at period end.
December 31, 2024
Carrying amount prior to remeasurement$4,038 
Impairment recognized in results of operations(372)
Fair value$3,666 
Significant unobservable inputs (Level 3) used in valuation of assets and liabilities measured at fair value on non recurring basis
The following table presents information as of December 31, 2024 about significant unobservable inputs (Level 3) used in the valuation of assets measured at fair value on a nonrecurring basis:
Financial instrumentFair
Value		Valuation TechniqueSignificant
Unobservable Inputs		Range of Inputs
Individually evaluated loans, net of allowance for credit losses$38,374 Appraised value of collateral less estimated costs to sellEstimated costs to sell
4-10%
OREO$3,666 Appraised value of property less estimated costs to sellEstimated costs to sell
4-10%
Summarizes differences between fair value and principal balance for mortgage loans held for sale measure at fair value
The following table summarizes the differences between the fair value and the principal balance for mortgage loans held for sale measured at fair value as of December 31, 2024 and December 31, 2023:
Aggregate
Fair Value		Aggregate
Unpaid
Principal
Balance		Difference
December 31, 2024
Mortgage loans held for sale measured at fair value$246,171 $244,218 $1,953 
December 31, 2023
Mortgage loans held for sale measured at fair value$179,756 $174,471 $5,285 
Schedule of assets and liabilities not measured and reported at fair value on a recurring basis or nonrecurring basis
The carrying amounts and estimated fair values of the Company’s financial instruments, including those assets and liabilities that are not measured and reported at fair value on a recurring basis or nonrecurring basis, were as follows as of the dates presented:
  Fair Value
 Carrying
Value		Level 1Level 2Level 3Total
December 31, 2024
Financial assets
Cash and cash equivalents$1,092,032 $1,092,032 $— $— $1,092,032 
Securities held to maturity1,126,112 — 1,002,544 — 1,002,544 
Securities available for sale831,013 — 831,013 — 831,013 
Loans held for sale246,171 — 246,171 — 246,171 
Loans, net12,683,264 — — 12,340,638 12,340,638 
Mortgage servicing rights72,991 — — 96,290 96,290 
Derivative instruments38,954 — 38,954 — 38,954 
Financial liabilities
Deposits$14,572,612 $12,093,327 $2,476,977 $— $14,570,304 
Short-term borrowings108,018 108,018 — — 108,018 
Junior subordinated debentures113,916 — 100,668 — 100,668 
Subordinated notes316,698 — 295,868 — 295,868 
Derivative instruments32,268 — 32,268 — 32,268 
  Fair Value
 Carrying
Value		Level 1Level 2Level 3Total
December 31, 2023
Financial assets
Cash and cash equivalents$801,351 $801,351 $— $— $801,351 
Securities held to maturity1,221,464 — 1,121,830 — 1,121,830 
Securities available for sale923,279 — 923,279 — 923,279 
Loans held for sale179,756 — 179,756 — 179,756 
Loans, net12,152,652 — — 11,594,363 11,594,363 
Mortgage servicing rights91,688 — — 117,664 117,664 
Derivative instruments37,151 — 37,151 — 37,151 
Financial liabilities
Deposits$14,076,785 $11,381,556 $2,678,494 $— $14,060,050 
Short-term borrowings307,577 307,577 — — 307,577 
Junior subordinated debentures112,978 — 96,435 — 96,435 
Subordinated notes316,422 — 255,192 — 255,192 
Derivative instruments33,608 — 33,608 — 33,608